# Mushroom Tree (Pterocarpus angolensis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/mushroom-tree-pterocarpus-angolensis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 1 / 10
**Category:** African
**Also Known As:** Pterocarpus angolensis DC., Muninga, Bloodwood Tree, Kiaat, Mukwa, Wild Teak, Transvaal Teak

## Overview

Pterocarpus angolensis stem bark and leaves contain epicatechin derivatives, lupane-type triterpenes, and isoflavonoids that disrupt bacterial and fungal cell integrity, inhibit parasitic chaperone proteins, and scavenge [reactive oxygen species](/ingredients/condition/antioxidant). In vitro, epicatechin-3-O-gallate achieves a minimum inhibitory concentration of 50 µg/mL against Staphylococcus aureus, while DCM/methanol bark extracts inhibit the malarial chaperone PfHsp70-1 with an IC₅₀ of 0.20 µg/mL, representing the most potent quantified bioactivity reported to date.

## Health Benefits

- **[Antimicrobial](/ingredients/condition/immune-support) Activity**: Epicatechin-3-O-gallate and a hexameric epicatechin isolated from stem bark disrupt cell wall and membrane integrity in gram-positive and gram-negative bacteria, achieving MIC values of 25–50 µg/mL against Staphylococcus aureus, Kocuria kristinae, and Acinetobacter calcoaceticus in vitro.
- **Antifungal Properties**: Methanolic and aqueous bark extracts demonstrate minimum fungicidal concentrations of 0.0417–0.166 g/mL against Candida species, supporting traditional use for oral and skin fungal infections including Tinea capitis, with tannins and flavonoids implicated as primary antifungal agents.
- **Antiplasmodial Potential**: DCM/methanol stem bark extracts inhibit Plasmodium falciparum heat shock proteins PfHsp70-z (IC₅₀ 13.87 µg/mL) and PfHsp70-1 (IC₅₀ 0.20 µg/mL), suggesting a chaperone-disruption mechanism relevant to antimalarial drug discovery.
- **Antioxidant Defense**: Bark extracts exhibit DPPH [free radical scaveng](/ingredients/condition/antioxidant)ing activity of up to 95.11% at 500 µg/mL, with an IC₅₀ of 150.64 µg/mL, attributed to the combined reducing capacity of tannins, flavonoids, and epicatechin gallates.
- **Antiamebic Activity**: Select isolated compounds, including epicatechin derivatives, inhibit Entamoeba histolytica in vitro with IC₅₀ values ranging from 25 to 100 µg/mL, providing a biochemical basis for traditional use in treating dysentery and gastrointestinal infections.
- **Ocular Infection Management**: In southern African ethnomedicine, leaf and bark decoctions are applied topically to treat eye infections and conjunctivitis; the antimicrobial profile against S. aureus and E. coli aligns with common bacterial causes of these conditions, though no clinical data confirm ophthalmic efficacy.
- **[Anti-Inflammatory](/ingredients/condition/inflammation) and Antiparasitic Use**: Triterpenes such as friedelan-3-one and lupeol acetate (3-acetoxyolean-12-en-28-oic acid) found in the bark possess structural scaffolds recognized in the literature for COX inhibition and antiparasitic action, lending phytochemical plausibility to traditional treatments for gonorrhea and intestinal parasites.

## Mechanism of Action

Epicatechin-3-O-gallate and its hexameric condensed tannin form act primarily by intercalating with bacterial membrane phospholipids and inhibiting peptidoglycan biosynthesis, collapsing transmembrane potential and causing cytoplasmic leakage in susceptible gram-positive organisms at MIC concentrations of 25–50 µg/mL. The DCM/methanol extract fraction targets Plasmodium falciparum cytosolic chaperones PfHsp70-z and PfHsp70-1, proteins essential for parasite protein folding and stress survival, with IC₅₀ values of 13.87 µg/mL and 0.20 µg/mL respectively, suggesting allosteric or active-site interference with ATPase-driven chaperone cycling. Phenolic compounds including tannins and flavonoids contribute to [antioxidant activity](/ingredients/condition/antioxidant) via hydrogen atom transfer and single electron transfer to DPPH radicals, achieving 95.11% scavenging at 500 µg/mL, while lupeol-type pentacyclic triterpenes likely modulate NF-κB-mediated [inflammatory](/ingredients/condition/inflammation) signaling based on structural analogy with documented congeners. Cytotoxicity observed for 3-hydroxyfriedel-3-en-2-one (brine shrimp LC₅₀ 100.8–147.9 µg/mL, selectivity index 0.93–1.35) indicates non-selective cell membrane disruption at higher concentrations, underscoring the need for therapeutic window characterization before clinical translation.

## Clinical Summary

There are no documented human clinical trials investigating Pterocarpus angolensis for any indication, including its primary traditional use in treating eye infections. All quantified outcomes derive from in vitro systems: MIC assays against bacterial and fungal pathogens, DPPH [antioxidant](/ingredients/condition/antioxidant) assays, parasite chaperone inhibition assays, and brine shrimp cytotoxicity screening. Effect sizes such as IC₅₀ 0.20 µg/mL for PfHsp70-1 inhibition and 95.11% DPPH scavenging at 500 µg/mL are biologically interesting but cannot be extrapolated to human therapeutic doses without bioavailability, [metabolism](/ingredients/condition/weight-management), and safety data. Confidence in any clinical benefit is low; the ingredient is best categorized as a candidate for preclinical development rather than an evidence-based therapeutic intervention.

## Nutritional Profile

Pterocarpus angolensis is not consumed as a food source and has no characterized macronutrient or conventional micronutrient profile. Its medicinal value lies entirely in secondary metabolites: stem bark contains triterpenes (friedelan-3-one, lupeol derivatives at ~0.0021% m/m yield for lup-20(29)-en-3-ol), isoflavonoids ((±)-4-O-methylangolensin), sterols (stigmasta-5,22-dien-3-ol), condensed tannins (epicatechin hexamers and epicatechin-3-O-gallate), chalcones, deoxybenzoins, and fatty acid esters (tetradecyl (E)-ferulate, dotriacontanoic acid). Leaf and fruit fractions are particularly rich in tannins and flavonoids, with methanolic leaf extract yields reaching 19.04% w/w, indicating high total polyphenol loading. Bioavailability of these compounds in humans is entirely unknown; the lipophilic triterpenes and tannins present in bark extracts would be expected to have low and variable oral bioavailability based on analogy with structurally related phytochemicals from other Pterocarpus species.

## Dosage & Preparation

- **Traditional Decoction (Bark)**: Stem bark is boiled in water for 15–30 minutes to produce a tea consumed orally for gastrointestinal and urogenital infections; no standardized volume or concentration is established.
- **Leaf Infusion (Topical/Ophthalmic)**: Fresh or dried leaves are steeped in hot water and the cooled liquid applied as an eyewash or skin wash for infections; preparation ratios and sterility are unstandardized.
- **Methanolic Extract (Research Grade)**: Yields up to 19.04% w/w from dried powdered bark; used in laboratory bioassays at concentrations of 25–500 µg/mL; no human-equivalent dose has been calculated.
- **DCM/Methanol Fractionated Extract**: Produced as a dry powder; demonstrates most potent antiplasmodial activity in vitro; not available in commercial supplement form.
- **Aqueous Root/Fruit Preparation**: Used in some traditions to exploit saponin and tannin content for antiparasitic purposes; preparation methods undocumented with pharmacological precision.
- **Dose Range Note**: In vitro active concentrations of 25–500 µg/mL cannot be directly translated to oral doses without bioavailability data; no safe or effective human dose has been established by any regulatory or scientific body.

## Safety & Drug Interactions

Human safety data for Pterocarpus angolensis are absent from the published literature; cytotoxicity inferred from in vitro brine shrimp assays shows LC₅₀ values ranging from 36.60 to 226.9 µg/mL for isolated fractions, with selectivity indices as low as 0.03 for some compounds, indicating a narrow or unfavorable therapeutic window at higher concentrations. The compound 3-hydroxyfriedel-3-en-2-one demonstrates greater cytotoxicity than the reference compound piperitenone in comparative assays (LC₅₀ 100.8–147.9 µg/mL, SI 0.93–1.35), raising concerns about non-selective cellular toxicity at therapeutic concentrations. No drug interactions have been formally studied; however, the presence of tannins at high concentrations may theoretically reduce oral absorption of iron supplements, antibiotics (particularly tetracyclines and fluoroquinolones), and alkaloid-based medications through chelation and precipitation. Use during pregnancy and lactation is contraindicated in the absence of safety data, and the tree's protected/endangered status in several jurisdictions further discourages unsupervised wild-harvesting and self-medication.

## Scientific Research

The entire body of published evidence for Pterocarpus angolensis consists exclusively of in vitro bioassays and phytochemical isolation studies; no peer-reviewed human clinical trials, randomized controlled trials, or animal pharmacokinetic studies were identified in the available literature as of the most recent search. [Antimicrobial](/ingredients/condition/immune-support) studies report MIC and MBC/MFC values across bacterial and fungal panels using disk diffusion and broth microdilution methods, but lack standardized extract characterization, making inter-study comparison unreliable. Antiplasmodial and antiamebic activities have been quantified using established cell-free and cell-based assays (PfHsp70 ATPase inhibition, E. histolytica trophozoite survival), providing mechanistically interpretable IC₅₀ data, yet these findings have not been replicated in animal models of infection. The overall evidence base is preliminary and exploratory; the absence of pharmacokinetic, toxicokinetic, or dose-escalation data in humans means that no efficacy or safety claims can be substantiated for clinical or supplemental use at this time.

## Historical & Cultural Context

Pterocarpus angolensis has been integral to the healing traditions of southern and central African communities — including Zulu, Shona, Tswana, and Mozambican ethnic groups — for centuries, with its distinctive red exudate symbolizing blood and vitality in cultural and ritual contexts. Traditional healers apply bark decoctions and leaf infusions to treat a broad spectrum of ailments including gonorrhea, diarrhea, dysentery, oral diseases, eye infections, and skin conditions caused by fungal pathogens such as Tinea capitis, reflecting a comprehensive [antimicrobial](/ingredients/condition/immune-support) folk pharmacopoeia. The tree also holds significant socioeconomic and spiritual importance as a premium timber species (Muninga wood), and in some traditions the sap itself is used topically as a wound sealant and anti-infective dressing, paralleling its laboratory-confirmed bioactivity against S. aureus and E. coli. Historical records and ethnobotanical surveys conducted across Zimbabwe, Tanzania, and South Africa consistently document its medicinal use, but formal documentation in classical pharmacopoeias such as the Ayurvedic or European herbal traditions is absent, reflecting its distinctly African ethnomedicinal identity.

## Synergistic Combinations

No formal combination studies have been conducted for Pterocarpus angolensis; however, its epicatechin-gallate fraction shares structural and mechanistic overlap with green tea catechins, suggesting potential additive [antimicrobial](/ingredients/condition/immune-support) effects when combined with EGCG-rich extracts through complementary membrane-disruption and enzyme-inhibition pathways. The antiplasmodial PfHsp70 inhibition mechanism is conceptually synergistic with artemisinin-based compounds that target different parasite survival pathways, though no co-administration data exist. Traditional African healers sometimes combine P. angolensis bark with Combretum molle or Sclerocarya birrea preparations for compound antimicrobial formulas, but these pairings have not been validated pharmacologically.

## Frequently Asked Questions

### What is Pterocarpus angolensis used for in traditional African medicine?

In southern and central African traditional medicine, Pterocarpus angolensis bark, leaves, and roots are used to treat eye infections, gonorrhea, diarrhea, dysentery, oral diseases, and skin infections caused by fungi such as Candida and Tinea capitis. Bark decoctions are consumed as teas for internal infections, while cooled leaf infusions are applied topically as eyewashes. These uses are supported by in vitro antimicrobial data but not yet by human clinical trials.

### Does Pterocarpus angolensis have any scientifically proven benefits?

Current evidence is limited to laboratory studies: epicatechin-3-O-gallate from the bark inhibits Staphylococcus aureus at an MIC of 50 µg/mL, and DCM/methanol extracts inhibit the malaria parasite chaperone PfHsp70-1 with an IC₅₀ of 0.20 µg/mL in vitro. DPPH antioxidant scavenging reaches 95.11% at 500 µg/mL. No human clinical trials have confirmed these effects translate to measurable health outcomes in people.

### Is Pterocarpus angolensis safe to use as a supplement or home remedy?

Safety cannot be confirmed because no human toxicology, pharmacokinetic, or clinical trial data have been published for this species. In vitro cytotoxicity studies show some isolated fractions have selectivity indices below 1.0, meaning cytotoxic concentrations overlap with bioactive concentrations in cell assays. Use during pregnancy or lactation is inadvisable, and self-treatment with uncharacterized bark extracts carries unknown risks of toxicity and drug interactions.

### How is Pterocarpus angolensis prepared as a traditional medicine?

Traditional preparations include boiling stem bark in water for 15–30 minutes to produce a decoction drunk for internal infections, or steeping dried leaves in hot water to make a cooled infusion used as a topical eyewash or skin rinse. Some communities also use root preparations to exploit saponin and tannin content for antiparasitic purposes. These methods are not standardized for dose or concentration, and no pharmaceutical-grade formulation exists commercially.

### What are the key bioactive compounds in Pterocarpus angolensis bark?

The stem bark is richest in epicatechin-3-O-gallate, a hexameric condensed tannin, lupane-type triterpenes (including lup-20(29)-en-3-ol at approximately 0.0021% m/m yield), friedelane triterpenes (friedelan-3-one, 3-hydroxyfriedel-3-en-2-one), the isoflavonoid (±)-4-O-methylangolensin, the sterol stigmasta-5,22-dien-3-ol, and fatty acid esters such as tetradecyl (E)-ferulate. Tannins and flavonoids are most concentrated in leaves and fruits, with methanolic leaf extracts yielding up to 19.04% w/w total extract.

### What is the difference between Pterocarpus angolensis bark extract and whole bark powder in terms of antimicrobial effectiveness?

Bark extracts, particularly methanolic and aqueous preparations, concentrate bioactive compounds like epicatechin-3-O-gallate and hexameric epicatechin, achieving measurable antimicrobial activity at MIC values of 25–50 µg/mL against pathogens like Staphylococcus aureus. Whole bark powder is less standardized and typically contains lower concentrations of these active compounds, making extracts potentially more potent for antimicrobial applications. However, whole powder may provide a broader spectrum of phytochemicals that work synergistically, though this advantage has not been extensively documented in clinical research.

### Does Pterocarpus angolensis interact with antibiotics or antifungal medications?

Given that Pterocarpus angolensis bark contains compounds with documented antimicrobial and antifungal properties, there is potential for additive or synergistic effects when combined with prescription antibiotics or antifungals, though specific drug interaction studies are lacking. This ingredient may theoretically amplify the effects of antimicrobial medications, which could be beneficial or problematic depending on dosing and individual response. It is advisable to consult a healthcare provider before using Pterocarpus angolensis alongside antimicrobial pharmaceuticals to avoid unintended interactions or compromised treatment efficacy.

### What does current research show about the strength of evidence for Pterocarpus angolensis antimicrobial and antifungal activity?

In vitro studies demonstrate promising antimicrobial activity, with bark extracts achieving clinically relevant MIC values against gram-positive and gram-negative bacteria, as well as documented antifungal properties in methanolic and aqueous preparations. However, evidence remains primarily laboratory-based, and clinical trials in humans are largely absent, limiting the ability to confirm these effects translate to real-world therapeutic benefit. More human studies are needed to establish dosage, efficacy, and safety profiles before making definitive claims about its effectiveness as a supplement or alternative to conventional antimicrobial treatments.

### What traditional uses does Pterocarpus angolensis have in African medicine?

Pterocarpus angolensis, commonly called Kiaat or Bloodwood, is used across southern and central Africa to treat eye infections, malaria, fever, skin conditions, and wounds, with the stem bark being the most frequently prepared plant part. Traditional healers apply bark decoctions topically or orally, practices that align mechanistically with the documented antimicrobial activity of epicatechin-3-O-gallate against gram-positive pathogens and the antiplasmodial chaperone inhibition identified in vitro. No clinical trials have validated these traditional applications in human populations.

### How does Pterocarpus angolensis compare to other antiplasmodial plant extracts?

The DCM/methanol bark extract's IC₅₀ of 0.20 µg/mL against PfHsp70-1 is notably potent compared to many reported plant-based antiplasmodial candidates, which typically show activity in the 1–100 µg/mL range against whole-parasite or target-based assays. This activity is attributed to interference with Plasmodium falciparum cytosolic chaperone cycling rather than the heme polymerization mechanism exploited by chloroquine, suggesting a distinct and potentially complementary mode of action. However, without in vivo pharmacokinetic data or parasite viability assays, direct comparative efficacy against standard antimalarials cannot be established.

### Are there any safety concerns or toxic effects associated with Pterocarpus angolensis extracts?

Brine shrimp cytotoxicity screening of the compound 3-hydroxyfriedel-3-en-2-one yielded an LC₅₀ of 100.8–147.9 µg/mL with a selectivity index of 0.93–1.35, indicating non-selective cytotoxicity where the toxic dose closely approaches the potentially active dose. This narrow or absent therapeutic window is a significant preclinical safety flag, suggesting membrane-disrupting activity at concentrations not far above bioactive ones. No mammalian toxicology, genotoxicity, or human adverse event data exist, so safe human dosing ranges cannot be defined from available evidence.

### Which specific compounds in Pterocarpus angolensis bark are responsible for its antioxidant activity?

Antioxidant activity reaching 95.11% DPPH scavenging at 500 µg/mL is primarily attributed to phenolic constituents including condensed tannins, epicatechin derivatives, and flavonoids present in the stem bark and leaf extracts. These compounds donate hydrogen atoms or single electrons to DPPH radicals via hydrogen atom transfer (HAT) and single electron transfer (SET) mechanisms, stabilising the radical and reducing oxidative stress in the assay system. Lupane-type triterpenes such as lupeol may contribute secondarily through indirect modulation of endogenous antioxidant pathways, though this has not been directly quantified for this species.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*